Drug lookup
Drug reference

Antithymocyte globulin (rabbit)

Immunosuppressant

Also known as Thymoglobulin, ATG, Antithymocyte immunoglobulin (rabbit)

Immunosuppressant
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
Manufacturer advises use only if potential benefit outweighs risk—no information available.
FDA category + note

Mechanism

Antithymocyte globulin (rabbit) is a polyclonal antibody purified from rabbit immunized with human thymic lymphocytes. It contains antibodies against many CD antigens as well as HLA antigens. It works by binding to T lymphocytes and depleting them, thereby providing a potent immunosuppressive effect.

Indications

Prophylaxis of organ rejection in renal allograft recipientsTreatment of corticosteroid-resistant allograft rejection in renal transplantation

Dosing

Adult
For prophylaxis of organ rejection in renal allograft recipients: 1–2.5 mg/kg daily for 3–5 days, to be given over at least 6 hours by intravenous infusion.…

Contraindications

  • Infection

Side effects

Common
ChillsDiarrhoeaDysphagiaDyspnoeaFeverHypotensionInfectionLymphopeniaMyalgiaNauseaNeoplasm malignantNeoplasmsNeutropeniaReactivation of infectionSecondary malignancySepsisSkin reactionsThrombocytopeniaVomiting
Serious
  • Cytokine release syndrome
  • Hepatic disorders
  • Hypersensitivity
  • Infusion related reaction

Pregnancy & lactation

Pregnancy

Manufacturer advises use only if potential benefit outweighs risk—no information available.

Lactation

Manufacturer advises avoid—no information available.

Related guidelines

Other Immunosuppressant drugs

Ask House about Antithymocyte globulin (rabbit)

Continue into a citation-backed clinical answer with the drug context already attached.